GSK plc (NYSE:GSK) confirmed the sale of 385.3 million shares in Haleon plc (NYSE:HLN) for $1.58 billion. The shares represented around 4.2% of the issued share capital of Haleon. Following the ...
The share sale and buyback are expected to reduce Pfizer's interest in Haleon from 32% to approximately 24%. In its fourth-quarter release, Haleon added that it expects to allocate £500 million to buy ...
LONDON - Days after carving out its consumer health business, a slimmed down GSK delivered a strong second-quarter ...
LONDON (Reuters Breakingviews) - GlaxoSmithKline’s personal health spinoff is beginning life with a target on its back. Haleon, maker of Advil painkillers and Sensodyne toothpaste, will next month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results